Clinical trial Recruiting at 1 site Interventional Ages 50 to 85

Velocity-Loss Resistance Training in Parkinson's Disease

Official title: Comparison of Neuromuscular and Functional Adaptations to 10% and 30% Velocity-Loss Threshold Resistance Training in Persons With Parkinson's Disease

Run by University of Miami · NCT07840508 · Data updated 2026-11-12

This trial tests whether two velocity-loss resistance training thresholds (10% vs 30%) improve muscle strength, power, and daily function in older adults with Parkinson's disease.

Quick facts

Study typeInterventional
Ages50 Years to 85 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Miami
Academic / other
Locations1 site (Coral Gables, Florida)
StatusRecruiting
StartedSeptember 25, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 28, 2026
Trial IDNCT07840508 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Parkinson's disease in Hoehn and Yahr stages 1–3 who can walk 50 meters unassisted and understand English.

Probably not a fit

Patients with more advanced Parkinson's disease, significant cardiovascular issues, inflammatory or autoimmune conditions, or limb injuries that prevent weight training may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares two velocity-loss resistance training protocols at 10% and 30% thresholds in adults with Parkinson's disease. Outcomes focus on changes in muscle strength, power, and performance in daily activities. The trial uses a controlled intervention design conducted in a university lab setting to gauge functional benefits and safety. Eligible participants are diagnosed with Parkinson's disease, Hoehn and Yahr stages 1–3, who can walk 50 meters and communicate in English. Exclusion criteria include uncontrolled cardiovascular or other neuromuscular conditions, inflammatory or autoimmune diseases, or limb injuries limiting weight training.

Why it matters

Potential benefit: If successful, participants may gain greater muscle strength and power, potentially improving everyday mobility and performance.

How similar studies have gone: Prior work on velocity-loss training in other populations suggests potential gains in strength and performance, but translation to Parkinson's disease remains to be demonstrated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parkinson's Disease Hoehn \& Yahr Stages 1-3
* Able to walk 50 meters unassisted
* Able to understand and communicate in English

Exclusion Criteria:

* Uncontrolled cardiovascular or other neuromuscular disease that prevent participation in a training program
* Any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, or other serious concomitant medical illness
* Unresolved injury or surgery to the upper or lower limbs that prevents weight training.

Where it's running

  • Laboratory of Neruomuscular Research and Active Aging
    Coral Gables, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Joseph F. Signorile, PhD — University of Miami - Coral Gables Campus
  • Study coordinator: Ethan A Elkins, MS
  • Email: exe453@miami.edu
  • Phone: 3052844173

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.